|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/664 | (2006.01) |
| A61P 35/00 | (2018.01) | ||
| A61K 31/675 | (2006.01) | ||
| A61K 31/7068 | (2013.01) | ||
| A61K 31/7068 | (2006.01) | ||
| A61K 31/675 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/664 | (2013.01) | ||
| A61K 31/685 | (2006.01) | ||
| A61P 1/18 | (2018.01) |
| (11) | Number of the document | 2817011 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13751188.7 |
| Date of filing the European patent application | 2013-02-21 | |
| (97) | Date of publication of the European application | 2014-12-31 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/027091 |
| Date | 2013-02-21 |
| (87) | Number | WO 2013/126539 |
| Date | 2013-08-29 |
| (30) | Number | Date | Country code |
| 201261601438 P | 2012-02-21 | US | |
| 201361756419 P | 2013-01-24 | US |
| (72) |
KROLL, Stewart , US
|
| (73) |
ImmunoGenesis, Inc. ,
909 Fannin, Suite 2000, Houston TX 77010,
US
|
| (54) | TREATMENT OF CANCER |
| TREATMENT OF CANCER |